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Aim To analyze how neural stem cells (NSC) transplanta-
tion in the stroke-affected mouse brain influences the 
expression of genes involved in apoptosis-inducing fac-
tor (AIF)-mediated cell death – apoptosis inducing fac-
tor mitochondria associated 1 (Aifm1), ring finger protein 
146 (Rnf146, Iduna), and cyclophilin A (CypA); necroptosis 
–receptor interaction protein kinase 1 (Ripk1), Ripk3, and 
mixed-lineage kinase domain-like protein (Mlkl); and apop-
tosis – Caspase 3 (Casp3) and Casp8.
Methods Four groups of animals were used to obtain 
mRNA for quantitative reverse transcription polymerase 
chain reaction analysis: healthy animals (n = 3), animals 
with stroke (n = 4), animals with stroke treated by stem cell 
transplantation (n = 7), and animals with stroke treated by 
proliferation-supporting medium (n = 5). Ischemic brain in-
jury was induced by transient left middle cerebral artery 
occlusion. Statistical analysis was performed using one-
way analysis of variance with post-hoc Tukey test.
Results NSC transplantation in the stroke-affected mouse 
brain significantly increased the expression of Iduna 
(P < 0.05), a gene-encoding protein with well-known pro-
tective effects on hypoxic damage, and significantly down-
regulated the expression of damage-supportive genes, 
Casp3 (P < .01) and Aifm1 (P < 0.001). We were able to distin-
guish between the effect produced by stem cell transplan-
tation (Iduna, Aifm1, Ripk3, Mlkl) and the effect produced 
by supporting the tissue with proliferation-supporting me-
dium (Ripk1, Casp8).
Conclusion Beside revealing some clearly positive effects 
of stem cells transplantation on the stroke-affected brain, 
our results suggest that the tissue response triggered by 
stem cells points toward the desired, regeneration-sup-
porting levels of expression of a certain gene at a certain 
time point.
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Ischemic brain stroke is one of the most devastating medi-
cal problems of the modern society, affecting more than 
20 million people every year. One fourth of the patients die 
and another fourth remain permanently disabled. The only 
available pharmacological treatment is intravenous ad-
ministration of recombinant tissue plasminogen activator, 
with a very limited number of candidates for its application 
(1). Despite advances in understanding of acute ischemic 
stroke mechanisms, more knowledge about the cellular 
pathways is needed to pave the way for the introduction 
of promising therapies such as stem cell transplantation.
Hypoxia/ischemia of the nervous tissue causes glutamate 
release and leads to subsequent oxidative toxicity and ex-
citotoxicity, which are combined with the activation of mo-
lecular pathways leading to programmed cell death (2,3). 
Some proteins, such as apoptosis-inducing factor (AIF) 
and cyclophilin A (CypA), important for AIF translocation 
to the nucleus (4), increase cell death. Others are activated 
as a part of cell rescue reaction, such as ring finger protein 
146 (RNF146, also called IDUNA), involved in DNA repair (5), 
which inhibits cell death after ischemia by preventing AIF 
translocation from the mitochondria (6). Growing evidence 
suggests that another modality of cell death, necroptosis, 
is specifically important in brain ischemia. Necroptosis is a 
type of regulated necrosis (7) involved in the pathophysiol-
ogy of ischemic stroke (8). It is mediated by receptor inter-
action protein kinase 1 (RIPK1), RIPK3, and mixed-lineage ki-
nase domain-like protein (MLKL). When activated by death 
receptors, RIPK1 and RIPK3 interact in a complex called 
necroptosome and phosphorylate MLKL, which then oli-
gomerizes and leads to necroptotic plasma membrane per-
meabilization (9). RIPK1 inhibition by necrostatin-1 (10) and 
MLKL inhibition by necrosulfonamide protect against isch-
emic brain injury (8,11). On the other hand, active Caspase 
8 (CASP8) inhibits necroptosis by cleaving RIPK1 and RIPK3, 
thus directing the cell to other types of responses (12).
There is growing evidence that stem cells transplantation 
measurably reduces the stroke area and accelerates re-
covery, both in preclinical (13-15) and clinical (16,17) trials. 
However, since the transplanted stem cells’ mechanisms of 
action in the injured tissue are not yet fully understood, we 
analyzed the influence of stem cell transplantation on the 
expression of genes involved in AIF-mediated cell death 
(Aifm1, Iduna, CypA), necroptosis (Ripk1, Ripk3, Mlkl), and 
apoptosis (Casp3, Casp8). Our hypothesis was that molec-
ular pathways linked to cell death were involved in the 
ischemic stroke pathophysiology and that stem cells 
transplantation influenced their expression.
MATERIALS AND METHODS
This study was performed in the Laboratory for Stem Cells, 
Croatian Institute for Brain Research, University of Zagreb 
School of Medicine in the period 2016–2018. All experi-
ments were carried out in accordance with the EU Direc-
tive 2010/63/EU on the protection of animals used for sci-
entific purposes and were approved by the Ministry of 
Agriculture (322-01/16-01/6) on September 1, 2015 and 
the Ethics Committee of the University of Zagreb School of 
Medicine (04-77/2010-238) on March 12, 2015.
Experimental design
Nineteen experimental animals were divided in 4 groups as 
follows: age-matched healthy mice (n = 3), stroke-affected 
mice (n = 4), stroke-affected mice transplanted with neu-
ral stem cells (NSC) (n = 4 for Iduna, CypA, and Casp8, n = 5 
for Ripk1, Ripk3, Mlkl, and Casp3, and n = 7 for Aifm1), and 
stroke-affected mice injected with growth factor-enriched 
medium without cells (n = 4 for Iduna, CypA, and Casp8, 
n = 5 for Aifm1, Ripk1, Ripk3, Mlkl, and Casp3). Stereotaxic 
injection of NSC or medium was performed 24 hours after 
brain injury. All procedures were performed by the same 
operator (IA), and animals were monitored every day. Two 
weeks after the stereotaxic injection, mice were sacrificed 
and tissues were harvested. We used animals with well-vis-
ible cortico-striatal stroke. After decapitation, the olfactory 
bulbs and cerebellum were removed, brains were divided 
into the left and right hemisphere, snap frozen in liquid 
nitrogen, and stored at -80°C. Total RNA was isolated, and 
quantitative reverse transcription polymerase chain reac-
tion (qRT-PCR) analysis was performed.
Animals and housing
Two mice strains were used: C57Bl/6NCrl (males for middle 
cerebral artery occlusion) and B6.Cg-Tg(Thy1-YFP)16Jrs/J 
(females for NSC isolation, The Jackson Laboratory, Bar Har-
bor, ME, USA). The animals were kept in the animal facility 
at the Croatian Institute for Brain Research at the tempera-
ture 22 ± 2°C, with 55% ± 10% humidity, and 12/12 h light/
dark cycle. Water and pelleted food were given ad libitum. 
Genotyping for strain confirmation for Thy1-YFP strain was 
performed using the published protocols (18).
Neural stem cells and cell culture
NSC were isolated from the telencephalic wall of the 
E14.5 fetuses as described previously (19). Briefly, on the 
205Hribljan et al: Stem cells, stroke, and cell death
www.cmj.hr
day 14.5 of pregnancy, females were sacrificed, and NSC 
were isolated using Accutase (Gibco by Life Technolo-
gies, A11105-01, Grand Island, NY, USA). Isolated cells 
were placed into the flasks in a specific proliferation-
supporting medium comprising DMEM/F-12 (Gibco by 
Life Technologies, 31331-028), B-27 Supplement (Gibco 
by Life Technologies, 17504-044), N-2 Supplement (Gib-
co by Life Technologies, 17502-048), Penicillin Strepto-
mycin (Gibco by Life Technologies, 15070-063), FGFb 
(Recombinant Mouse Fibroblast Growth Factor-basic, 
PMG0035), and EGF (Recombinant Mouse Epidermal 
Growth Factor, PMG8041). Cells were cultivated in sus-
pension, and after two days neurospheres were formed. 
Neurospheres were dissociated by Accutase and re-sus-
pended in the concentration of 1000 000 cells in 1 µL of 
DMEM medium.
Mouse stroke model – transient middle cerebral artery 
occlusion
Ischemic brain injury was induced by transient left middle 
cerebral artery occlusion (tMCAO) (20) in 3-month-old wild 
type mice weighing 25-30 g. Surgery was performed un-
der inhalation anesthesia, mixture 2% isoflurane in 100% 
O2, under dissection microscope (Stemi DV4 Spot, Zeiss, 
Oberkochen, Germany). During surgery, animal body tem-
perature was maintained with a heating pad. Following 
ventral neck surgery and blood vessels preparation, in-
traluminal filament (Doccol Company, Sharon, MA, USA) 
was inserted through the common carotid artery into the 
internal carotid artery, rostral to the origin of the middle 
cerebral artery, and left for 90 minutes. After 90 minutes, 
intraluminal filament was withdrawn, perfusion was re-
stored, and the animal intraperitoneally received analgetic 
buprenorphine (0.03 mg/kg).
Stereotaxic injection into the mouse brain
For stereotaxic injection, we used stroke-affected mice 
that received NSC and stroke-affected mice that received 
proliferation-supporting medium alone. Stroke-affected 
mice were injected 24 hours after the brain injury. Cells or 
proliferation-supporting medium were injected into the 
striatum (Anterior-Posterior −0.5, Medial-Lateral +2.5 and 
Dorsal-Ventral −2.5) according to the stereotaxic atlas us-
ing KOPF stereotaxic apparatus 900LS (David Kopf Instru-
ments, Tujunga, CA, USA) and Hamilton syringe needle 1 
µL. For anesthesia, Avertin (Sigma-Aldrich, St. Louis, MO, 
USA; T48402-5G) was used at a dose of 0.5 g/kg, given 
intraperitoneally. After injection, mice were placed on a 
warm heating pad, allowed to wake up, and returned to 
their cages.
Tissue harvesting and storage
Two weeks after injection, mice were sacrificed by cervical 
dislocation, and each hemisphere was snap-frozen in liq-
uid nitrogen and stored at -80°C.
Quantitative reverse transcription polymerase chain 
reaction
Total RNA was isolated by commercial RNeasy® Mini Kit 
(Qiagen, Hilden, Germany) following the manufacturer’s 
instructions. Concentration was calculated on a spectro-
photometer (Nanodrop, Thermo Fisher Scientific, Waltham, 
MA, USA), and RNA was converted to single-stranded cDNA 
using high capacity RNA-to-cDNA Kit (Applied Biosystems, 
Foster City, CA, USA). Assays used in this study are listed 
in Table 1, while the normalization was performed with 
β-Actin (ACTB MGB 4352933E) (TaqMan Gene Expression 
Assays; Thermo Fisher Scientific). All samples were made 
in duplicate with 1 µg cDNA in a total volume of 20 µL us-
ing Applied Biosystems 7500 Real-Time PCR System. The 
comparative CT method (2-ΔCT) was used for relative gene 
expression analysis.
Statistical analysis
The sample number was determined by availability of exper-
imental animals and it corresponds to standards in such ex-
periments (21). The normality of distribution was tested using 
Shapiro-Wilk test. All variables are expressed as mean ± stan-
dard deviation. Statistical significance of between-group dif-
ferences was tested using the analysis of variance (ANOVA) 
with post-hoc Tukey test. The level of significance was set at 
P < 0.05, P < 0.01, and P < 0.001. Statistical analysis was per-
formed using GraphPad Prism 5 (La Jolla, CA, USA, free 
trial version registered to our Laboratory).
TAbLE 1. TaqMan® Gene Expression Assays (Applied biosys-
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RESULTS
Expression of genes involved in AIF-mediated cell 
death
Aifm1 level in the ipsilateral hemisphere was significantly 
increased by stroke (P < 0.001) (Figure 1A) and significant-
ly reduced by NSC transplantation (P < 0.001). Injection of 
proliferation-supporting medium, surprisingly, increased 
its level in both hemispheres (Figure 1A). In the contralat-
eral hemisphere, Aifm1 level was not increased by stroke, 
but was significantly reduced by NSC transplantation 
(P < 0.001), when compared to both healthy and stroke-
affected group.
Iduna level in the ipsilateral hemisphere was down-regu-
lated by stroke, but not significantly (Figure 1B). It was sig-
nificantly increased by NSC transplantation (P < 0.01) and 
non-significantly increased by the injection of prolifera-
tion-supporting medium. The same pattern was observed 
in the contralateral hemisphere, but without significant 
differences (Figure 1B).
CypA level in the ipsilateral hemisphere was significant-
ly decreased by stroke (Figure 1C), NSC transplantation, 
and the injection of proliferation-supporting medium 
(P < 0.001, for all groups). In the contralateral hemisphere, 
a similar pattern was observed, but without significant dif-
ferences (Figure 1C).
FIGURE 1. Relative expression levels of apoptosis-inducing factor mitochondria associated 1 (Aifm1) (A), ring finger protein 146 
(Rnf146, Iduna) (B), and cyclophilin A (CypA) (C) in the ipsilateral (left, LH) and contralateral (right, RH) hemisphere. Groups involved 
include healthy mice (circles, H), stroke-affected mice (stars, S), stroke-affected mice transplanted with neural stem cells (squares, 
S+C), and stroke-affected mice transplanted with proliferation-supporting medium without cells (triangles, S+M). mRNA levels of 
each gene are shown as a percentage of endogenous control levels (β-Actin). Whiskers show mean ± standard deviation. Differences 
between groups were considered significant if P < 0.05 (*), P < 0.01(**), and P < 0.001 (***).
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Expression of genes involved in necroptosis and 
apoptosis
Ripk1 and Casp8 expression in the ipsilateral hemisphere 
followed the same pattern: they were significantly up-
regulated by stroke (P < 0.01 for Ripk1 and P < 0.001 for 
Casp8) and reduced by NSC transplantation and the injec-
tion of proliferation-supporting medium to levels similar 
to healthy mice (Figure 2A-E). In the contralateral hemi-
sphere, there was no significant difference in Ripk1 expres-
sion between the groups. Casp8 expression was reduced 
by both NSC transplantation and the injection of prolifer-
ation-supporting medium when compared with healthy 
and stroke-affected group.
FIGURE 2. Relative expression levels of receptor interaction protein kinase 1 (Ripk1) (A), Ripk3 (B), mixed-lineage kinase domain-like 
protein (Mlkl) (C), caspase 3 (Casp3) (D) and Casp8 (E) in the ipsilateral (left, LH) and contralateral (right, RH) hemisphere. The follow-
ing groups were involved: healthy mice (circles, H), stroke-affected mice (stars, S), stroke-affected mice transplanted with neural stem 
cells (squares, S+C), and stroke-affected mice transplanted with proliferation-supporting medium without cells (triangles, S+M). 
mRNA levels of each gene are shown as the percentage of endogenous control levels (β-Actin). Whiskers show mean ± standard 
deviation. Differences between groups were considered significant if P < 0.05 (*), P < 0.01(**), and P < 0.001 (***).
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Ripk3 and Mlkl in the ipsilateral hemisphere followed the 
same expression pattern: they were significantly increased 
by stroke (P < 0.01 for Ripk3 and P < 0.001 for Mlkl) and re-
duced by the injection of proliferation-supporting medi-
um (significant for Mlkl P < 0.01), but not by NSC transplan-
tation (Figure 2B and 2C). This unique phenomenon was 
also found in the contralateral hemisphere.
Casp3 level in the ipsilateral hemisphere was decreased 
after stroke compared with healthy controls, but the dif-
ference was not significant. It was significantly reduced by 
NSC transplantation compared with healthy mice. In the 
contralateral hemisphere, there was no significant differ-
ence between the groups (Figure 2D).
DISCUSSION
We showed that NSC transplantation significantly influ-
enced the expression of genes linked to different modali-
ties of cell death after stroke (Figure 3). Fourteen days af-
ter the onset of the ischemic brain damage, the majority 
of genes involved in promoting cell death exhibited in-
creased expression levels (Casp8, Aifm1, Ripk1, Ripk3, and 
Mlkl), while one gene that opposed this direction was 
down-regulated (Iduna). In only one case, a cell death-pro-
moting gene, CypA was down-regulated, which suggested 
the presence of a strong endogenous reparative mecha-
nism. Thus, we confirmed our hypothesis that stem cells 
significantly influenced the expression of genes linked 
to cell death. In addition, we showed that all three major 
markers of necroptosis (Ripk1, Ripk3, Mlkl) were significantly 
increased after ischemic brain damage. This corresponds 
to their hypothesized role in cell death in the nervous tis-
sue following hypoxia (24).
We analyzed the potential role of transplanted NSC in 
supporting tissue recovery. In the majority of brain dis-
eases, expected benefits from cell transplantation cover 
a whole spectrum, involving modulation of inflammation, 
cell rescue, and cell replacement. We have already shown 
that different stem cell populations exhibit different ben-
eficial effects on disease-affected nervous tissue (25). Al-
though some studies, both on preclinical and clinical 
levels, described mechanisms responsible for beneficial 
effects, including effects on transplanted cells (26), many 
of them focused on description of cell fates (27) or report-
ed beneficial effects, while the mechanisms themselves 
remained elusive. Most studies analyzing cell death re-
ported only one or a few markers, mostly focusing on 
classic apoptotic pathways, like Casp3 (28). One of 
the rare studies that analyzed a wider array of genes in 
the rat model of stroke showed that transplantation of 
human umbilical cord mesenchymal stem cells reduced 
apoptosis markers (29).
To obtain insight into the possible role of the programmed 
cell death mediated by AIF, we analyzed the expression of 
Aifm1, Iduna, and CypA. AIF is linked to glutamate toxici-
ty and Aifm1 seems to be one of the most potent genes 
for general control over cell death. Aifm1 levels can be re-
duced, leading to abnormal cell survival, as observed in 
some human tumor types (30), but also increased, like in 
the case of hypoxic damage. Our finding that Aifm1 expres-
sion was increased after tMCAO but significantly reduced 
and normalized after NSC transplantation highly suggests 
a protective role of NSC transplantation. More importantly, 
we discovered positive effects of NSC transplantation, in-
cluding a huge up-regulation of Iduna levels. IDUNA has 
protective effects on cells, including its strong antioxida-
tive (31) and antiglutamate (32) effects and effects linked 
to the rescue of cells from a fatal G1 arrest and facilitation of 
DNA repair (5). Specific for brain damage, Iduna was clearly 
shown to be down-regulated in brain ischemia, which is 
directly linked to increased cell damage (32). Moreover, the 
rescue of Iduna in neurons correlates with ischemic dam-
age decrease (33). Our study is the very first to report that 
NSC transplantation significantly up-regulates Iduna levels. 
This means that NSC simultaneously down-regulate Aifm1 
and up-regulate Iduna, which is a combination with a pos-
sibly enormous protective effect on ischemia-affected tis-
sue. Furthermore, we also showed that NSC transplanta-
tion after a stroke caused one more positive effect – Casp3 
down-regulation.
By selecting 14 days after stroke onset as the measure-
ment time point, we deliberately aimed at the transition 
from sub-acute to chronic phase, including both removal 
of cells damaged by ischemia and regeneration. This raises 
the question of whether the significantly down-regulated 
or up-regulated gene levels are linked to the pathological 
process occurring, thus mirroring the negative events, or 
completely opposite – whether the remaining tissue aims 
to change the gene expression levels because this is need-
ed for regeneration. Our study suggests that the part of the 
answer can be found in the tissue treated by transplanted 
stem cells. The presence of transplanted stem cells sup-
ports regenerative events (13,14,17). For example, stroke 
increases the levels of Ripk1, a necroptosis promotor, while 
transplanted medium and NSC oppose this process (Figure 
2A). The opposite example is CypA. Its down-regulation 14 
209Hribljan et al: Stem cells, stroke, and cell death
www.cmj.hr
days after stroke onset cannot be observed in the same 
way as Iduna down-regulation. Iduna is a well-known pro-
tective gene, whose down-regulation is a marker of neg-
ative effect of hypoxia, corrected by up-regulation found 
after NSC transplantation. Indeed, in this case, CypA down-
regulation after 14 days is likely an endogenous regenera-
tive, protective response of the brain tissue, as was seen in 
animals treated with NSC in our study. Bearing this in mind, 
the pattern observed for Ripk1, Ripk3, and Mlkl is most in-
teresting. While both the proliferation-supporting medium 
and NSC significantly reduced Ripk1 expression, they had 
different effects on Ripk3 and Mlkl: the medium suppressed 
Ripk3 and Mlkl expression and NSC increased it. RIPK1 inhi-
bition by necrostatin-1 (10) and MLKL inhibition by necro-
sulfonamide protects against ischemic brain injury (8,11). 
On the other hand, RIPK3-deficient mice were not protect-
FIGURE 3. Scheme of molecular pathways of apoptosis-inducing factor (AIF)-mediated cell death, necroptosis, and apoptosis follow-
ing stroke. Proteins for which genes were analyzed are shown in gray circles. Symbols on each side represent expression pattern of 
genes from the corresponding hemisphere: the ipsilateral hemisphere to the left and the contralateral hemisphere to the right. black 
circle represents healthy mice, star represents stroke-affected mice, square represents stroke-affected mice transplanted with neural 
stem cells, and triangle represents stroke-affected mice transplanted with proliferation-supporting medium without cells. Gluta-
mate, which is released following stroke, causes oxidative stress by inhibiting cystine-glutamate antiporter (Xc-) and depleting the 
intracellular pool of glutathione, increasing intracellular Ca2+, which leads to oxidative toxicity (oxytosis) (2). Glutamate can also bind 
to N-methyl-D-aspartate (NMDA) receptors inducing Ca2+ influx and direct excitotoxicity (3). both excitotoxicity and oxytosis cause 
the AIF release from outer mitochondria membrane and its translocation to the nucleus, which leads to cell death. Protein IDUNA 
has a protective role because it decreases AIF nuclear translocation (3). On the other hand, CYPA is a pro-cell death protein, shown 
to be important for AIF translocation to the nucleus, and inhibition of AIF/CYPA complex has been shown to be protective against 
oxidative stress-induced cell death pathways. Cell death in nervous system can also be triggered by binding of inducers of cell death 
to death receptors, causing at least two different types of cell death: apoptosis and necroptosis. Activated death receptors induce 
RIPK1 phosphorylation, which then phosphorylates RIPK3 and makes with it a complex, called necroptosome (9). The necroptosome 
phosphorylates MLKL, which then oligomerizes and causes necroptotic plasma membrane permeabilization. If active Caspase 8 
(CASP8) is present in the cytoplasm, it inhibits necroptosis by cleaving RIPK1 and RIPK3, and this directs the cell to apoptosis, which 
is executed by CASP3 (12). besides being involved in necroptosis, mixed-lineage kinase domain-like protein (MLKL) is also found in 
the “necroptotic bodies,” which can be phagocytosed (22) and is important for the assembly of extracellular vesicles with inflam-
matory mediators (23). Abbreviations: Aifm1 –apoptosis inducing factor mitochondria associated 1; Rnf146 – ring finger protein 
146 (Iduna); CypA – cyclophilin A; TNF – tumor necrosis factor; Xc- Cys/Glu – cystine/glutamate antiporter; Ca2+ – calcium ion; 
GSH – glutathione; ROS – reactive oxygen species; P – phosphorylated; Casp – caspase.
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ed against tMCAO-induced stroke compared with their 
wild type counterparts (34). This leads to the suggestion 
that NSC transplantation yields an opposite effect, that is, 
that it maintains the high Ripk3 and Mlkl levels. One of the 
possible explanations could be that Ripk1 is the major ge-
netic activator of the necroptotic complex. Its controlling 
action is very clearly negative for the ischemia-affected 
tissue. Moreover, MLKL regulates endosomal trafficking, 
while RIPK3 boosts vesicles release, which altogether with-
holds cell death (23). Our results, therefore, suggest that, 
when aiming at necroptosis, Ripk1 should be decreased, 
while Ripk3 and Mlkl activation might not be so harmful.
This study analyzed gene expression in the whole hemi-
sphere, which presents a limitation because we cannot 
determine in which cell type the observed changes occur. 
For example, we showed that Casp8, Ripk1, and Ripk3 were 
up-regulated following stroke, although it has been shown 
that CASP8 blocks assembly of necroptotic complex com-
posed of RIPK1 and RIPK3, leading the cell to apoptosis 
(12). It is possible that Casp8 might be up-regulated in one 
cell type and Ripk1 and Ripk3 in another. Also, we showed 
that Ripk3 and Mlkl levels were up-regulated following 
stroke and reduced by the proliferation-supporting medi-
um, but their high expression levels were maintained by 
NCS. MLKL, besides being involved in necroptosis, is found 
in the “necroptotic bodies,” which can be phagocytosed 
(22), and is involved in assembling of extracellular vesicles, 
which contain inflammatory mediators (23). Therefore, 
Ripk3 and Mlkl up-regulation might not be as harmful as 
previously thought, and in some cases might be needed 
for tissue recovery. Further research is needed to deter-
mine in which cell type and brain region this up-regula-
tion occurs and whether its role is protective or damage-
supportive. In addition, a limitation of our study was that 
the sample size was determined according to previous 
similar research and was not calculated before conducting 
the research. However, post-hoc power analysis with test 
strength of 80% confirmed that the number of animals per 
group was sufficient.
In conclusion, this study revealed an important role of dif-
ferent types of cell death in the pathophysiology of isch-
emic stroke. Even more importantly, it demonstrated that 
NSC transplantation up-regulated Iduna, a gene linked to 
regeneration, and down-regulated genes linked to cell 
death (Aifm1, Casp3). Moreover, our model can be used 
to get insight in the effects of a certain gene at a certain 
time point. Direction of change in gene expression af-
ter NSC transplantation, especially if this change is 
very pronounced and significant, may suggests whether 
it is beneficial to activate or to block the expression of a 
certain gene if regeneration of hypoxia-affected tissue is 
to be improved.
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